StockWatch
·
Pharmaceuticals
Board Meeting7 Aug 2026, 07:30 pm

Jeena Sikho Lifecare Board Approves Q1 FY27 Unaudited Results

AI Summary

Jeena Sikho Lifecare Limited announced that its Board of Directors has approved the unaudited financial results for the quarter ended June 30, 2026, both on a standalone and consolidated basis. The board also approved the limited review reports from the statutory auditors. Additionally, the board approved the re-appointment of Mr. Karan Vir Bindra as an Independent Director, Mrs. Bhavna Grover as a Whole-time Director, and Mr. Manish Grover as Managing Director, all subject to shareholder approval for a second term of five years.

Key Highlights

  • Board approved unaudited financial results for Q1 FY27.
  • Results were approved on standalone and consolidated basis.
  • Limited review reports were also approved.
  • Re-appointment of key directors approved, pending shareholder nod.
  • Director re-appointments are for a five-year term.